KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,730 | -35.4% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q3 2023 | $2,680 | -25.1% | 2,000 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $3,580 | +44650.0% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $8 | +14.3% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $7 | -99.9% | 2,000 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $11,000 | +22.2% | 2,000 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $9,000 | -52.6% | 2,000 | -33.3% | 0.01% | -41.7% |
| Q1 2022 | $19,000 | 0.0% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $19,000 | +11.8% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $17,000 | +70.0% | 3,000 | +200.0% | 0.01% | +71.4% |
| Q2 2021 | $10,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |